Last reviewed · How we verify
NCT05483725
Immunological Safety and Effectiveness of the First Booster Dose of mRNA Vaccines Against COVID-19 in Kidney Transplant Recipients.
trial testing Booster dose of mRNA vaccine in Kidney Diseases in 108 participants. Status unknown.
4 December 2024
Quick facts
| Lead sponsor | Institute for Clinical and Experimental Medicine |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 108 |
| Start date | 4 October 2021 |
| Primary completion | 4 December 2024 |
| Estimated completion | 31 December 2024 |
| Sites | 1 location across Czechia |
Drugs / interventions tested
- Booster dose of mRNA vaccine — full drug profile →
Conditions studied
- Kidney Diseases — all drugs for Kidney Diseases →
- Kidney Transplant; Complications — all drugs for Kidney Transplant; Complications →
- COVID-19 — all drugs for COVID-19 →
- Vaccine Adverse Reaction — all drugs for Vaccine Adverse Reaction →
Sponsor
Institute for Clinical and Experimental Medicine
Who can join
18 and older, any sex, with Kidney Diseases or Kidney Transplant; Complications. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Prospective observational trial to assess immunological safety (anti-HLA antibodies, donor-derived cell-free DNA) and immunological effectiveness (anti-SARS-CoV-2 IgG) of the first booster dose of SARS-CoV-2 mRNA vaccines in kidney transplant recipients at least one year from transplantation.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine Booster Doses in Kidney Transplant Recipients: Results of a 12-mo Follow-up From a Prospective Observational Study.
Petr V, Zahradka I, Modos I, Roder M, et al · · 2024 · cited 1× · PMID 38769974 · DOI 10.1097/txd.0000000000001645
Verify or expand the search:
- PubMed search for NCT05483725
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Kidney Diseases
Currently open trials in the same condition.
- NCT07444203 — Transformative Research in Diabetic Nephropathy 2.0 · recruiting
- NCT07217535 — Rutgers University Study of the Genetics of Kidney Disease · recruiting
- NCT06858319 — Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy. · Phase 3 · recruiting
- NCT06798909 — Kidney Transplant Preemptive Therapy or Prophylaxis for CMV Prevention in D+R Recipients · Phase 3 · recruiting
- NCT06759077 — Cardio Protective Effect of SGL2I in Hemodialysis Patients and Its Impact on Patient Quality of Life · Phase 3 · active not recruiting
Other Institute for Clinical and Experimental Medicine trials
Trials by the same sponsor.
- NCT07536087 — Endoscopic Ultrasound-Guided Radiofrequency Ablation for Pancreatic Cystic Neoplasms and Pancreatic Neuroendocrine Tumor · NA · recruiting
- NCT07527156 — Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure · Phase 4 · recruiting
- NCT07326826 — Hernia Repair Using Rectus Fascia Allograft · not yet recruiting
- NCT06872255 — Per-oral Endoscopic Myotomy (POEM) in Patients with Postfundplication Dysphagia · NA · not yet recruiting
- NCT07153432 — Chronic Kidney Disease Screening · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05483725 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Institute for Clinical and Experimental Medicine
- Last refreshed: 6 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05483725.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing